A new monoclonal antibody is now available for the treatment of severe Covid after a recent FDA emergency use authorization.
FDA Authorizes New Antibody Treatment For Severe Covid-19
A new monoclonal antibody is now available for the treatment of severe Covid after a recent FDA emergency use authorization.